.jpg)
COMPOUNDS DERIVED FROM QUINONES AND THEIR USE AGAINST LEISHMANIA spp.
Patent number:
P202030581
No items found.
The present invention relates to compounds derived from quinones with leishmanicidal activity and their use thereof in the pharmaceutical sector, specifically in the field of parasitic diseases. Specifically, it relates to compounds of formula I, their isomeric forms and salts thereof.
Countries:
Spain
Regions:
Canary Islands
Centers:
UNIVERSIDAD DE LA LAGUNA
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
SDG03: Good health and well-being
Applications
Application for use in the treatment of leishmaniasis. - High efficacy - Low toxicity. - Significant improvement over reference treatment with Miltefosine. - Synthetic procedure from readily available and low cost commercial compounds instead of extraction from natural source.
Comments